13,14-dihydro-15-keto Prostaglandin D2-d4 (13,14-dihydro-15-keto PGD2-d4) contains four deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of 13,14-dihydro-15-keto PGD2 by GC- or LC-mass spectrometry. 13,14-dihydro-15-keto PGD2 is a metabolite of PGD2 which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor.1 It also inhibits ion flux in a canine colonic mucosa preparation.2 In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.3,4
1.Rangachari, P.K., and Betti, P.A.Biological activity of metabolites of PGD2 on canine proximal colonAm. J. Physiol.264(5 Pt 1)G886-G894(1993)
2.Hirai, H., Tanaka, K., Yoshie, O., et al.Prostaglandin D2 selectivity induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2J. Exp. Med.193(2)255-261(2001)
3.Liston, T.E., and Roberts, L.J., IIMetabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteerJ. Biol. Chem.260(24)13172-13180(1985)
4.Morrow, J.D., Prakash, C., Awad, J.A., et al.Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assayAnal. Biochem.193(1)142-148(1991)
